The NCCN guidelines also state that indications for high-penetrance breast cancer and/or ovarian cancer include susceptibility genes such as BRCA1, BRCA2, PTEN, TP53, CDH1, and others [43]. This evidence concerns the gene BRCA1 and ovarian carcinoma.